224 related articles for article (PubMed ID: 19407474)
1. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
[TBL] [Abstract][Full Text] [Related]
2. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.
Kastl S; Brunner T; Herrmann O; Riepl M; Fietkau R; Grabenbauer G; Sauer R; Hohenberger W; Klein P
Eur J Surg Oncol; 2000 Sep; 26(6):578-82. PubMed ID: 11034809
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
Staley CA; Lee JE; Cleary KR; Abbruzzese JL; Fenoglio CJ; Rich TA; Evans DB
Am J Surg; 1996 Jan; 171(1):118-24; discussion 124-5. PubMed ID: 8554125
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
9. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
11. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
12. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
Idelevich E; Buyevich V; Machlenkin S; Ziv-Sokolovsky N; Dinerman M; Brenner B; Kashtan H
Onkologie; 2008 Dec; 31(12):673-7. PubMed ID: 19060505
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
Swartz MJ; Hughes MA; Frassica DA; Herman J; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
Arch Surg; 2007 Mar; 142(3):285-8. PubMed ID: 17372054
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in advanced gastric cancer--results of a pilot study.
Shukla NK; Deo SV; Asthana S; Raina V; Dronamaraju SS
Trop Gastroenterol; 2002; 23(2):94-6. PubMed ID: 12632980
[TBL] [Abstract][Full Text] [Related]
19. Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-alpha in pancreatic and periampullary cancer: results of a feasibility study.
Nitsche M; Horstmann O; Christiansen H; Hermann RM; Hess CF; Becker H; Pradier O; Schmidberger H
Cancer Radiother; 2008 Dec; 12(8):817-21. PubMed ID: 18996727
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration.
Geisler JP; Manahan KJ; Buller RE
Gynecol Oncol; 2006 Jan; 100(1):53-7. PubMed ID: 16257042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
